HRT Financial’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,497
Closed -$175K 3709
2025
Q2
$175K Buy
+19,497
New +$116K ﹤0.01% 2102
2024
Q2
Sell
-14,855
Closed -$130K 3143
2024
Q1
$130K Buy
+14,855
New +$121K ﹤0.01% 1836
2021
Q4
Sell
-18,915
Closed -$133K 4111
2021
Q3
$133K Sell
18,915
-8,140
-30% -$65.6K ﹤0.01% 2821
2021
Q2
$226K Buy
+27,055
New +$233K ﹤0.01% 2321
2020
Q3
Sell
-13,722
Closed -$96K 2379
2020
Q2
$96K Buy
+13,722
New +$100K ﹤0.01% 1250

Other funds holding ULBI

HRT Financial's ULBI Position: Q3 2025 in Review

HRT Financial sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 19,497 shares — an estimated $175K sold.

HRT Financial first reported a position in ULBI in Q2 2020 and held it in 5 quarters. The position peaked at $226K in Q2 2021. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • HRT Financial reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 19,497 Ultralife shares in Q3 2025, an estimated $175K.
  • HRT Financial first reported a position in Ultralife in Q2 2020 and held it in 5 quarters.
  • HRT Financial's Ultralife position peaked at $226K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.